Abstract 6P
Background
Lymph nodes (LN) act as central hubs for the orchestration of adaptive immune responses. A network of lymph node stromal cells (LNSC), including mesenchymal and endothelial cells, build a 3D network for immune cells to migrate and home to distinct niches in the LN. Within B cell non-Hodgkin lymphomas, indolent follicular lymphomas (FL) are characterized by subtle structural changes while the compartmentalization of the tissue remains present. In contrast, aggressive diffuse large B cell lymphomas (DLBCL) are defined by a complete loss of tissue organization indicating a potential role of LNSCs in tumorigenesis. While the morphological differences are well-known, the underlying molecular and cellular mechanisms remain poorly understood.
Methods
Here, we dissect the mechanisms underlying loss of structure in lymphomagenesis using combined single-cell transcriptome and spatially-resolved mapping approaches of LNSCs and immune cells.
Results
Using ultra-high plex immunofluorescence imaging, we characterized how lymph node cells organize into spatially distinct cellular neighborhoods, the disruption of which was congruent with lymphoma-induced remodeling. Using single-cell transcriptome data, we investigated the molecular programs driving this loss of organization. In DLBCL, chemokines relevant for immune cell organization were downregulated, while chemokines contributing to inflammation were upregulated, suggesting a phenotypic switch from a structural organized to an inflammatory and fibrotic state. In silico cell-cell interaction analysis indicated that besides the loss of mesenchyme-derived chemokine gradients, inflammatory immune cells outside of follicles turn into ectopic sources of these chemokines, an effect which likely contributes to the diffuse growth pattern of aggressive lymphomas. High expression of organizing chemokines was associated with better overall survival, this association being significant in FL and a trend in DLBCL.
Conclusions
Collectively, these data suggest that a reprogramming of the LN microenvironment triggers an imbalance in chemokine gradients, which underlies loss of tissue organization in aggressive lymphomas.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
57P - Metastasis organotropism: Unveiling associated proteins using network biology
Presenter: Margarida Carrolo
Session: Poster session 09
59P - Correlation of tumor microenvironment signature in advanced stage non-small cell lung cancer with EGFR mutation who received EGFR-TKIs
Presenter: Chaiyapong Ngamchokwathana
Session: Poster session 09
60P - Establishment and characterization of a novel lung adenocarcinoma cell line HX-JCJ harboring MET ex14 skipping mutation
Presenter: Xuejin Ou
Session: Poster session 09
61P - Next generation sequencing and its clinical utility in advanced cancer: Single institute experience from low-middle income country
Presenter: Amit Badola
Session: Poster session 09
62P - Prebiotics modulate gut microbiota-mediated T cell immunity to enhance sintilimab inhibition of lung cancer
Presenter: QIN YAN
Session: Poster session 09
63P - Addition of human chorionic gonadotropin to the current standard mobilization approach with granulocyte-colony stimulating factor increases overall survival in a murine model of peripheral blood stem cell transplantation: Are we far enough for therapy?
Presenter: Andrei Cismaru
Session: Poster session 09
64P - Developing novel therapeutics for bladder cancer leveraging drosophila models
Presenter: Takuya Moriguchi
Session: Poster session 09
65P - Ionizing radiation induces vascular smooth muscle cell senescence through activating NF-κB-CTCF-p16 pathway
Presenter: xuefeng zheng
Session: Poster session 09
66P - Exploring the radiobiology and dosimetry of targeted alpha therapy as a tool to optimize its clinical application: A preclinical study
Presenter: Maria Filomena Botelho
Session: Poster session 09
67P - The effect of non-viral gene-immune therapy via OX40L or 4-1BBL on murine subcutaneous CT26 colon cancer model
Presenter: Olga Rakitina
Session: Poster session 09